Personal tools

T-ALL workshop

March 17-19, 2017 - Leuven, Belgium

T-cell acute lymphoblastic leukemia is an aggressive leukemia of immature T-cells with a peak incidence in young children. Improved treatment schedules, patient stratification and minimal residual disease (MRD) monitoring has significantly improved survival of T-ALL patients, now reaching up to 80% in children and 50% in adults. Molecular studies performed over the last 20 years have provided a detailed view on the genomic changes that occur during T-ALL development. More recently, also first insights in the origins of relapse have been discovered.

After two highly successful T-ALL workshops in 2010 and 2013, this third T-ALL workshop will bring together over 150 of international delegates working in the field of T-ALL. This will provide a unique opportunity to get updated on and discuss the various aspects of T-ALL research: from basic research, over translational research, to clinical trial updates.

Topics will include:

  • Normal T-cell development
  • Genomic, transcriptomic and proteomic studies in T-ALL
  • Deregulated signaling pathways in T-ALL compared to normal T-cell signaling
  • Transcription factors & epigenetics
  • Animal models of T-ALL
  • New drug targets and new drugs
  • Mechanisms of relapse

Sessions include: 10 invited speakers, 16 speakers selected from abstracts, 40 poster pitches (2 minute talk/1 slide introductory talks for the posters), and poster sessions at lunch and with Belgian beers, time for questions and coffee breaks to continue interactions with speakers & participants.

We are looking forward to welcoming you in Leuven and to your participation in this interactive workshop.

Dates: Friday March 17 (starting at 3pm), Saturday March 18 & Sunday March 19, 2017 (ending at noon)

Contact e-mail:

We are honored to annouce :

Keynote Speakers :

  • A. Thomas Look (Dana-Farber, Harvard Medical School, Boston, MA, USA)
  • Charles Mullighan (St. Jude Children's Research Hospital, TN, USA)
  • Nicola Gökbuget (University Hospital Frankfurt, Goethe University, Germany)
  • Hans-Reimer Rodewald (DKFZ, Heidelberg, Germany)

Invited speakers:

  • Jon Aster (Brigham and Women's Hospital, Boston, USA)
  • EACR Sponsored Lecture: João T Barata (University of Lisbon, Lisbon, Portugal)
  • Kim De Keersmaecker, KU Leuven, Leuven, Belgium
  • David Curtis (Monash University, Victoria, Australia)
  • Trang Hoang (Université de Montréal, Montréal, Canada)
  • Cristina Lo Celso (Imperial College London, London, UK)
  • Frank Staal (LUCM, Leiden, The Netherlands)


  • Jan Cools (VIB - KU Leuven, Leuven, Belgium)
  • Kim De Keersmaecker (KU Leuven, Leuven, Belgium)
  • Pieter Van Vlierberghe (U Gent, Gent, Belgium)
  • Adolfo Ferrando (Columbia University, New York, NY, USA)
  • Jules Meijerink (Erasmus Medical Center, Rotterdam, The Netherlands)
  • Jean Soulier (Hôpital Saint Louis, Paris, France)
  • Last modified 15-03-2017